# Extended Analysis for Leukemia/Lymphoma Treatment

> **NCT03096821** · — · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 143 (actual)

## Conditions studied

- Relapsed Hematologic Malignancy

## Interventions

- **DRUG:** ngFDS selected treatment

## Key facts

- **NCT ID:** NCT03096821
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03096821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03096821, "Extended Analysis for Leukemia/Lymphoma Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03096821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*